| Rank |
Title |
Year |
PubWeight™‹?› |
|
1
|
Liver Injury from Herbal, Dietary, and Weight Loss Supplements: a Review.
|
2015
|
1.03
|
|
2
|
Acetaminophen-induced Liver Injury: from Animal Models to Humans.
|
2014
|
1.01
|
|
3
|
Drug- and Herb-Induced Liver Injury in Clinical and Translational Hepatology: Causality Assessment Methods, Quo Vadis?
|
2013
|
0.96
|
|
4
|
Treatment of Nonalcoholic Fatty Liver Disease: The Role of Medical, Surgical, and Endoscopic Weight Loss.
|
2015
|
0.95
|
|
5
|
Acetaminophen-Induced Hepatotoxicity: a Comprehensive Update.
|
2016
|
0.93
|
|
6
|
Epidemiology of Hepatitis B Virus Infection in China: Current Status and Challenges.
|
2014
|
0.92
|
|
7
|
Biomarker-based MicroRNA Therapeutic Strategies for Hepatocellular Carcinoma.
|
2014
|
0.90
|
|
8
|
Hepatocellular Carcinoma and Liver Transplantation: State of the Art.
|
2014
|
0.90
|
|
9
|
Hepatobiliary Tumors: Update on Diagnosis and Management.
|
2015
|
0.89
|
|
10
|
Current Knowledge on Hepatitis E.
|
2015
|
0.89
|
|
11
|
Update on Autoimmune Hepatitis.
|
2015
|
0.89
|
|
12
|
Diagnosis and Management of Alcoholic Liver Disease.
|
2015
|
0.89
|
|
13
|
Sofosbuvir, a Significant Paradigm Change in HCV Treatment.
|
2015
|
0.88
|
|
14
|
Diagnosis of Liver Involvement in Primary Sjögren Syndrome.
|
2013
|
0.87
|
|
15
|
Dermatologic Extrahepatic Manifestations of Hepatitis C.
|
2015
|
0.86
|
|
16
|
Management of Hepatitis C Post-liver Transplantation: a Comprehensive Review.
|
2015
|
0.86
|
|
17
|
Hepatobiliary Schistosomiasis.
|
2014
|
0.85
|
|
18
|
Hepatitis C Virus, Insulin Resistance, and Steatosis.
|
2016
|
0.85
|
|
19
|
Autoimmune Hepatitis: Clinical Review with Insights into the Purinergic Mechanism of Disease.
|
2013
|
0.83
|
|
20
|
Diabetes Mellitus Predicts Occurrence of Cirrhosis and Hepatocellular Cancer in Alcoholic Liver and Non-alcoholic Fatty Liver Diseases.
|
2015
|
0.83
|
|
21
|
Hepatitis C Associated B-cell Non-Hodgkin Lymphoma: Clinical Features and the Role of Antiviral Therapy.
|
2015
|
0.82
|
|
22
|
Nonalcoholic Fatty Liver Disease: Dyslipidemia, Risk for Cardiovascular Complications, and Treatment Strategy.
|
2015
|
0.82
|
|
23
|
Hepatic Sarcoidosis.
|
2013
|
0.82
|
|
24
|
IL-6 Plays a Crucial Role in HBV Infection.
|
2015
|
0.82
|
|
25
|
Ascitic Fluid Analysis in the Differential Diagnosis of Ascites: Focus on Cirrhotic Ascites.
|
2014
|
0.82
|
|
26
|
Hepatic Echinococcal Cysts: A Review.
|
2016
|
0.82
|
|
27
|
Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, and Prevention.
|
2013
|
0.81
|
|
28
|
Update on Alcohol and Viral Hepatitis.
|
2014
|
0.81
|
|
29
|
Hepatopulmonary Syndrome and Liver Transplantation: A Recent Review of the Literature.
|
2016
|
0.81
|
|
30
|
Inhibitor-Based Therapeutics for Treatment of Viral Hepatitis.
|
2016
|
0.81
|
|
31
|
An Update on Treatment of Drug-Induced Liver Injury.
|
2014
|
0.81
|
|
32
|
Current Management of Alcoholic Hepatitis and Future Therapies.
|
2016
|
0.80
|
|
33
|
Direct-acting Antiviral Agents for the Treatment of Chronic Hepatitis C Virus Infection.
|
2014
|
0.80
|
|
34
|
TM6SF2 E167K Variant, a Novel Genetic Susceptibility Variant, Contributing to Nonalcoholic Fatty Liver Disease.
|
2015
|
0.80
|
|
35
|
Drug Induced Liver Injury: Review with a Focus on Genetic Factors, Tissue Diagnosis, and Treatment Options.
|
2015
|
0.80
|
|
36
|
The Role of Immune Cells in Chronic HBV Infection.
|
2015
|
0.80
|
|
37
|
Antiviral Therapy of Liver Cirrhosis Related to Hepatitis B Virus Infection.
|
2014
|
0.80
|
|
38
|
Acute Hepatic Porphyria.
|
2015
|
0.80
|
|
39
|
Chinese Herbal Medicine-induced Liver Injury.
|
2014
|
0.79
|
|
40
|
Prophylaxis against Recurrence in Liver Transplantation Patients with Hepatitis B Virus: What is New?
|
2014
|
0.79
|
|
41
|
Genome-Wide Association Study Reveals Host Genetic Factors for Liver Diseases.
|
2013
|
0.79
|
|
42
|
Autochthonous Hepatitis E Virus Infection in Europe: A Matter of Concern for Public Health?
|
2014
|
0.79
|
|
43
|
MicroRNAs as Important Players in Host-hepatitis B Virus Interactions.
|
2015
|
0.79
|
|
44
|
Peginterferon Lambda-1a, a New Therapeutic for Hepatitis C Infection, from Bench to Clinic.
|
2013
|
0.79
|
|
45
|
Acute Hepatic Phenotype of Wilson Disease: Clinical Features of Acute Episodes and Chronic Lesions Remaining in Survivors.
|
2015
|
0.79
|
|
46
|
The Discovery and Development of a Potent Antiviral Drug, Entecavir, for the Treatment of Chronic Hepatitis B.
|
2013
|
0.78
|
|
47
|
Percutaneous Cryoablation for Liver Cancer.
|
2014
|
0.78
|
|
48
|
Risk Factors for the Development of Hepatocellular Carcinoma in Thailand.
|
2015
|
0.78
|
|
49
|
Thrombosis Associated with Viral Hepatitis.
|
2014
|
0.78
|
|
50
|
Hepatitis B and Delta Virus: Advances on Studies about Interactions between the Two Viruses and the Infected Hepatocyte.
|
2015
|
0.78
|